Melanoma Journal Articles

 
 
  • Avoid Unnecessary Naevi Biopsies in High-Risk Melanoma? Can supplementing dermoscopy and digital follow-up with in vivo reflectance confocal microscopy in patients at high-risk of melanoma reduce the need for excisional biopsies?
  • Screening of Individuals at High Risk of Cutaneous Melanoma Are existing guidelines for the screening and follow-up of patients at high risk for cutaneous melanoma adequate? This review makes recommendations for improving the quality of current guidelines.
  • Current and Emerging Therapies for Bone Metastatic CRPC Find out more about new therapies that show promise in improving overall survival rates in patients with bone metastatic castration resistant prostate cancer.
  • Dermoscopy of Small Melanomas: Just Miniaturized Dermoscopy? Do micromelanomas have specific dermoscopic features which might enable early diagnosis?
  • Melanoma Arising in Association With Blue Nevus The authors describe the clinical and histopathologic features of melanomas arising in association with common or cellular blue nevi. How do these features correlate with clinical outcome?
  • Toxicity of Checkpoint Inhibitors Learn more about a new class of antineoplastic drugs whose mechanism of action depends on interaction with the immune system.
  • More Skin, More Sun, More Tan, More Melanoma This interesting review traces the continued rise in melanoma in the 20th century via changing social norms; from fashion, art and advertising, to the rise in outdoor leisure-time activities.
  • Algorithm for Management of Metastatic Cutaneous Melanoma Find out how best to integrate the currently available treatment options for cutaneous melanoma in various clinical scenarios.
  • Sentinel Lymph Node Biopsy in Melanoma Get results from the final report from MSLT-I with 10-year follow up data for patients with intermediate and thick primary melanomas.
  • Sentinel Node Biopsy Plus Excision for Cutaneous Melanoma Is sentinel node biopsy beneficial in patients who undergo wide, local excision for primary cutaneous melanoma?
  • Delivery of Peptides for Anti-Tumor Immunotherapy Could nanotechnology-based delivery of antigenic peptides be feasible for efficiently inducing anti-tumor cytotoxic T lymphocyte responses?
  • Alcohol Drinking and Cutaneous Melanoma Risk Might regular alcohol use increase melanoma risk? This meta-analysis investigated the relationship between alcohol consumption and cutaneous melanoma.
  • Metastatic Melanoma: Managing Dermatologic Toxicities While new treatments for metastatic melanoma have improved survival for many patients, they also may have significant cutaneous adverse effects. What does the dermatologist need to know?
  • Trametinib: An Oral MEK Inhibitor for Metastatic Melanoma The FDA recently approved trametinib, a first-in-class, oral MEK inhibitor for patients with unresectable or metastatic melanoma with BRAF V600/K mutations. What are the implications?
  • Sentinel Lymph Node Biopsy in Melanoma Get current data regarding patient selection for SLNB in melanoma and learn about areas where the procedure remains controversial. . .
  • A GP Training Campaign for Early Detection of Melanoma Can an educational program targeted at GPs and using dermatologists as trainers improve melanoma screening in the primary care setting?
  • Targeted Melanoma Prevention Intervention Is a targeted screening and education intervention more effective than conventional information for improving melanoma awareness and skin self-examination in high-risk patients?
  • Radiotherapy for Lentigo Maligna The authors present recommendations for radiotherapy of lentigo maligna based on their experience from a multidisciplinary lentigo maligna clinic.
  • Novel Treatments for Melanoma Brain Metastases Treating patients with melanoma brain metastases is a major therapeutic challenge. Should surgery and radiotherapy be the go-to the options?
  • Comparison of Worldwide Melanoma Guidelines This review looks at the evidence and available literature for the management of melanoma worldwide. How do guidelines differ among the major expert groups?
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.